1、Chan CC, Sen HN. Current concepts in diagnosing and managing
primary vitreoretinal (intraocular) lymphoma[ J]. Discov Med, 2013,
15(81): 93-100.Chan CC, Sen HN. Current concepts in diagnosing and managing
primary vitreoretinal (intraocular) lymphoma[ J]. Discov Med, 2013,
15(81): 93-100.
2、Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal
lymphoma: a report from an International Primary Central Nervous
System Lymphoma Collaborative Group symposium[ J]. Oncologist,
2011, 16(11): 1589-1599.Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal
lymphoma: a report from an International Primary Central Nervous
System Lymphoma Collaborative Group symposium[ J]. Oncologist,
2011, 16(11): 1589-1599.
3、Kuo DE, Wei MM, Knickelbein JE, et al. Logistic Regression
Classification of Primary Vitreoretinal Lymphoma versus Uveitis by
Interleukin 6 and Interleukin 10 Levels[ J]. Ophthalmology, 2020,
127(7): 956-962.Kuo DE, Wei MM, Knickelbein JE, et al. Logistic Regression
Classification of Primary Vitreoretinal Lymphoma versus Uveitis by
Interleukin 6 and Interleukin 10 Levels[ J]. Ophthalmology, 2020,
127(7): 956-962.
4、Cho BJ, Yu HG. Risk factors for intraocular involvement in patients
with primary central nervous system lymphoma[ J]. J Neurooncol,
2014, 120(3): 523-529Cho BJ, Yu HG. Risk factors for intraocular involvement in patients
with primary central nervous system lymphoma[ J]. J Neurooncol,
2014, 120(3): 523-529
5、DeAngelis LM, Yahalom J, Thaler HT, et al. Combined modality
therapy for primary CNS lymphoma[ J]. J Clin Oncol, 1992, 10(4):
635-643.DeAngelis LM, Yahalom J, Thaler HT, et al. Combined modality
therapy for primary CNS lymphoma[ J]. J Clin Oncol, 1992, 10(4):
635-643.
6、Berenbom A, Davila RM, Lin HS, et al. Treatment outcomes for
primary intraocular lymphoma: implications for external beam
radiotherapy[ J]. Eye (Lond), 2007, 21(9): 1198-1201.Berenbom A, Davila RM, Lin HS, et al. Treatment outcomes for
primary intraocular lymphoma: implications for external beam
radiotherapy[ J]. Eye (Lond), 2007, 21(9): 1198-1201.
7、Buettner H, Bolling JP. Intravitreal large-cell lymphoma[ J]. Mayo Clin
Proc, 1993, 68(10): 1011-1015.Buettner H, Bolling JP. Intravitreal large-cell lymphoma[ J]. Mayo Clin
Proc, 1993, 68(10): 1011-1015.
8、Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma[ J]. Cancer, 1993, 72(3): 843-849.Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma[ J]. Cancer, 1993, 72(3): 843-849.
9、Tsubota K, Usui Y, Goto H, et al. Identification of prognostic markers
in patients with primary vitreoretinal lymphoma by clustering analysis
using clinical data[ J]. J Clin Med, 2020, 9(7): 2298.Tsubota K, Usui Y, Goto H, et al. Identification of prognostic markers
in patients with primary vitreoretinal lymphoma by clustering analysis
using clinical data[ J]. J Clin Med, 2020, 9(7): 2298.
10、Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous
system lymphoma: clinical features and diagnosis[ J]. Ocul Immunol
Inflamm, 2000, 8(4): 243-250.Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous
system lymphoma: clinical features and diagnosis[ J]. Ocul Immunol
Inflamm, 2000, 8(4): 243-250.
11、Ban Y, Okamoto M, Ogata N, et al. Case of primary intraocular
lymphoproliferative disorder caused by Epstein-Barr Virus[ J]. BMC
Ophthalmol, 2020, 20(1): 306.Ban Y, Okamoto M, Ogata N, et al. Case of primary intraocular
lymphoproliferative disorder caused by Epstein-Barr Virus[ J]. BMC
Ophthalmol, 2020, 20(1): 306.
12、Harris NL, Jaffe ES, Diebold J, et al. World Health Organization
classification of neoplastic diseases of the hematopoietic and
lymphoid tissues: report of the Clinical Advisory Committee
meeting-Airlie House, Virginia, November 1997[ J]. J Clin Oncol,
1999, 17(12): 3835-3849.Harris NL, Jaffe ES, Diebold J, et al. World Health Organization
classification of neoplastic diseases of the hematopoietic and
lymphoid tissues: report of the Clinical Advisory Committee
meeting-Airlie House, Virginia, November 1997[ J]. J Clin Oncol,
1999, 17(12): 3835-3849.
13、Shen DF, Herbort CP, Tuaillon N, et al. Detection of Toxoplasma
gondii DNA in primary intraocular B-cell lymphoma[ J]. Mod Pathol,
2001, 14(10): 995-999.Shen DF, Herbort CP, Tuaillon N, et al. Detection of Toxoplasma
gondii DNA in primary intraocular B-cell lymphoma[ J]. Mod Pathol,
2001, 14(10): 995-999.
14、Chan CC. Molecular pathology of primary intraocular lymphoma[ J].
Trans Am Ophthalmol Soc, 2003, 101: 275-292.Chan CC. Molecular pathology of primary intraocular lymphoma[ J].
Trans Am Ophthalmol Soc, 2003, 101: 275-292.
15、Chan CC. Primary intraocular lymphoma: clinical features, diagnosis,
and treatment[ J]. Clin Lymphoma, 2003, 4(1): 30-31.Chan CC. Primary intraocular lymphoma: clinical features, diagnosis,
and treatment[ J]. Clin Lymphoma, 2003, 4(1): 30-31.
16、Hoffman PM, McKelvie P, Hall AJ, et al. Intraocular lymphoma: a
series of 14 patients with clinicopathological features and treatment
outcomes[ J]. Eye (Lond), 2003, 17(4): 513-521.Hoffman PM, McKelvie P, Hall AJ, et al. Intraocular lymphoma: a
series of 14 patients with clinicopathological features and treatment
outcomes[ J]. Eye (Lond), 2003, 17(4): 513-521.
17、Kimura K, Usui Y, Goto H, et al. Clinical features and diagnostic
significance of the intraocular fluid of 217 patients with intraocular
lymphoma[ J]. Jpn J Ophthalmol, 2012, 56(4): 383-389.Kimura K, Usui Y, Goto H, et al. Clinical features and diagnostic
significance of the intraocular fluid of 217 patients with intraocular
lymphoma[ J]. Jpn J Ophthalmol, 2012, 56(4): 383-389.
18、Hwang CS, Yeh S, Bergstrom CS, et al. [ J]. Int Ophthalmol Clin, 2014,
54(2): 155-171.Hwang CS, Yeh S, Bergstrom CS, et al. [ J]. Int Ophthalmol Clin, 2014,
54(2): 155-171.
19、Gill MK, Jampol LM. Variations in the presentation of primary
intraocular lymphoma: case reports and a review[ J]. Surv Ophthalmol,
2001, 45(6): 463-471.Gill MK, Jampol LM. Variations in the presentation of primary
intraocular lymphoma: case reports and a review[ J]. Surv Ophthalmol,
2001, 45(6): 463-471.
20、Kanavi MR, Soheilian M, Bijanzadeh B, et al. Diagnostic vitrectomy
(25-gauge) in a case with intraocular lymphoma masquerading as
bilateral granulomatous panuveitis[ J]. Eur J Ophthalmol, 2010, 20(4):
795-798.Kanavi MR, Soheilian M, Bijanzadeh B, et al. Diagnostic vitrectomy
(25-gauge) in a case with intraocular lymphoma masquerading as
bilateral granulomatous panuveitis[ J]. Eur J Ophthalmol, 2010, 20(4):
795-798.
21、Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma
with intraocular involvement: International PCNSL Collaborative
Group Report[ J]. Neurology, 2008, 71(17): 1355-1360.Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma
with intraocular involvement: International PCNSL Collaborative
Group Report[ J]. Neurology, 2008, 71(17): 1355-1360.
22、Buggage RR, Chan CC, Nussenblatt RB, et al. Ocular manifestations of
central nervous system lymphoma[ J]. Curr Opin Oncol, 2001, 13(3):
137-142.Buggage RR, Chan CC, Nussenblatt RB, et al. Ocular manifestations of
central nervous system lymphoma[ J]. Curr Opin Oncol, 2001, 13(3):
137-142.
23、Almas T, Stephenson KA, Ehtesham M, et al. Beware the quiet eye:
primary vitreoretinal lymphoma masquerading as posterior uveitis[ J].
BMJ Case Rep, 2020, 13(12): 240802.Almas T, Stephenson KA, Ehtesham M, et al. Beware the quiet eye:
primary vitreoretinal lymphoma masquerading as posterior uveitis[ J].
BMJ Case Rep, 2020, 13(12): 240802.
24、Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein,
indocyanine green angiography, and optic coherence tomography in
non-Hodgkin primary intraocular lymphoma[ J]. Am J Ophthalmol,
2009, 147(5): 886-94, 894.e1.Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein,
indocyanine green angiography, and optic coherence tomography in
non-Hodgkin primary intraocular lymphoma[ J]. Am J Ophthalmol,
2009, 147(5): 886-94, 894.e1.
25、Casady M, Faia L, Nazemzadeh M, et al. Fundus autofluorescence
patterns in primary intraocular lymphoma[ J]. Retina, 2014, 34(2):
366-372.Casady M, Faia L, Nazemzadeh M, et al. Fundus autofluorescence
patterns in primary intraocular lymphoma[ J]. Retina, 2014, 34(2):
366-372.
26、Levy-Clarke GA, Byrnes GA, Buggage RR, et al. Primary intraocular
lymphoma diagnosed by fine needle aspiration biopsy of a subretinal
lesion[ J]. Retina, 2001, 21(3): 281-284.Levy-Clarke GA, Byrnes GA, Buggage RR, et al. Primary intraocular
lymphoma diagnosed by fine needle aspiration biopsy of a subretinal
lesion[ J]. Retina, 2001, 21(3): 281-284.
27、Wang G, Peng X. A review of clinical applications and side effects
of methotrexate in ophthalmology[ J]. J Ophthalmol, 2020, 2020:
1537689.Wang G, Peng X. A review of clinical applications and side effects
of methotrexate in ophthalmology[ J]. J Ophthalmol, 2020, 2020:
1537689.
28、Meleth AD, Sen HN. Use of fundus autofluorescence in the
diagnosis and management of uveitis[ J]. Int Ophthalmol Clin,
2012, 52(4): 45-54.Meleth AD, Sen HN. Use of fundus autofluorescence in the
diagnosis and management of uveitis[ J]. Int Ophthalmol Clin,
2012, 52(4): 45-54.
29、张永鹏, 李志华, 杨文利, 等. 原发性葡萄膜淋巴瘤四例[ J]. 中华
眼底病杂志, 2020, 36(6): 447-452.
ZHANG YP, LI ZH, YANG WL, et al. The clinical features
of primary uveal lymphoma of four cases[ J]. Chinese Journal of Ocular
Fundus Diseases, 2020, 36(6): 447-452.张永鹏, 李志华, 杨文利, 等. 原发性葡萄膜淋巴瘤四例[ J]. 中华
眼底病杂志, 2020, 36(6): 447-452.
ZHANG YP, LI ZH, YANG WL, et al. The clinical features
of primary uveal lymphoma of four cases[ J]. Chinese Journal of Ocular
Fundus Diseases, 2020, 36(6): 447-452.
30、Jusufbegovic D, Kim V, Char DH, et al. Primary uveal lymphoma with
epibulbar extension masquerading as an intraocular inflammation[ J].
Can J Ophthalmol, 2015, 50(1): e24-e26.Jusufbegovic D, Kim V, Char DH, et al. Primary uveal lymphoma with
epibulbar extension masquerading as an intraocular inflammation[ J].
Can J Ophthalmol, 2015, 50(1): e24-e26.
31、Mashayekhi A, Shukla SY, Shields JA, et al. Choroidal lymphoma:
clinical features and association with systemic lymphoma[ J].
Ophthalmology, 2014, 121(1): 342-351.Mashayekhi A, Shukla SY, Shields JA, et al. Choroidal lymphoma:
clinical features and association with systemic lymphoma[ J].
Ophthalmology, 2014, 121(1): 342-351.
32、Aronow ME, Portell CA, Sweetenham JW, et al. Uveal lymphoma:
clinical features, diagnostic studies, treatment selection, and
outcomes[ J]. Ophthalmology, 2014, 121(1): 334-341.Aronow ME, Portell CA, Sweetenham JW, et al. Uveal lymphoma:
clinical features, diagnostic studies, treatment selection, and
outcomes[ J]. Ophthalmology, 2014, 121(1): 334-341.
33、Bedaiwi K, Alfawaz AM, Mohammed SF, et al. Intraocular T-cell
lymphoma metastasizing from a primary adrenal T-cell lymphoma:
Case report[ J]. Ann Med Surg (Lond), 2020, 60: 646-650.
Bedaiwi K, Alfawaz AM, Mohammed SF, et al. Intraocular T-cell
lymphoma metastasizing from a primary adrenal T-cell lymphoma:
Case report[ J]. Ann Med Surg (Lond), 2020, 60: 646-650.
34、Abu Samra K, Oray M, Ebrahimiadib N, et al. Intraocular lymphoma:
descriptive data of 26 patients including clinico-pathologic features,
vitreous findings, and treatment outcomes[ J]. Ocul Immunol Inflamm,
2018, 26(3): 347-352.Abu Samra K, Oray M, Ebrahimiadib N, et al. Intraocular lymphoma:
descriptive data of 26 patients including clinico-pathologic features,
vitreous findings, and treatment outcomes[ J]. Ocul Immunol Inflamm,
2018, 26(3): 347-352.
35、Maruyama K, Kunikata H, Sugita S, et al. First case of primary
intraocular natural killer t-cell lymphoma[ J]. BMC Ophthalmol, 2015,
15: 169.Maruyama K, Kunikata H, Sugita S, et al. First case of primary
intraocular natural killer t-cell lymphoma[ J]. BMC Ophthalmol, 2015,
15: 169.
36、Lin TC, Lin PY, Wang LC, et al. Intraocular involvement of T-cell
lymphoma presenting as inflammatory glaucoma, neurotrophic
keratopathy, and choroidal detachment[ J]. J Chin Med Assoc, 2014,
77(7): 385-388.Lin TC, Lin PY, Wang LC, et al. Intraocular involvement of T-cell
lymphoma presenting as inflammatory glaucoma, neurotrophic
keratopathy, and choroidal detachment[ J]. J Chin Med Assoc, 2014,
77(7): 385-388.
37、Levy-Clarke GA , Greenman D, Sieving PC, et al. Ophthalmic
manifestations, cytology, immunohistochemistry, and molecular
analysis of intraocular metastatic T-cell lymphoma: report of a case and
review of the literature[ J]. Surv Ophthalmol, 2008, 53(3): 285-295.Levy-Clarke GA , Greenman D, Sieving PC, et al. Ophthalmic
manifestations, cytology, immunohistochemistry, and molecular
analysis of intraocular metastatic T-cell lymphoma: report of a case and
review of the literature[ J]. Surv Ophthalmol, 2008, 53(3): 285-295.
38、Küker W, N?gele T, Korfel A, et al. Primary central nervous system
lymphomas (PCNSL): MRI features at presentation in 100 patients[ J].
J Neurooncol, 2005, 72(2): 169-177.Küker W, N?gele T, Korfel A, et al. Primary central nervous system
lymphomas (PCNSL): MRI features at presentation in 100 patients[ J].
J Neurooncol, 2005, 72(2): 169-177.
39、Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment
of primary CNS lymphoma in immunocompetent patients: guidelines
from the European Association for Neuro-Oncology[ J]. Lancet Oncol,
2015, 16(7): e322-e332.Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment
of primary CNS lymphoma in immunocompetent patients: guidelines
from the European Association for Neuro-Oncology[ J]. Lancet Oncol,
2015, 16(7): e322-e332.
40、Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma:
an International Primary Central Nervous System Lymphoma
Collaborative Group Report[ J]. Ann Oncol, 2007, 18(11): 1851-1855.Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma:
an International Primary Central Nervous System Lymphoma
Collaborative Group Report[ J]. Ann Oncol, 2007, 18(11): 1851-1855.
41、Char DH, Kemlitz AE, Miller T, et al. Intraocular biopsy[ J].
Ophthalmol Clin North Am, 2005, 18(1): 177-85, x.Char DH, Kemlitz AE, Miller T, et al. Intraocular biopsy[ J].
Ophthalmol Clin North Am, 2005, 18(1): 177-85, x.
42、Mastropasqua R, Thaung C, Pavesio C, et al. The role of chorioretinal
biopsy in the diagnosis of intraocular lymphoma[ J]. Am J Ophthalmol,
2015, 160(6): 1127-1132.e1.Mastropasqua R, Thaung C, Pavesio C, et al. The role of chorioretinal
biopsy in the diagnosis of intraocular lymphoma[ J]. Am J Ophthalmol,
2015, 160(6): 1127-1132.e1.
43、Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of
vitrectomy specimens and chorioretinal biopsies in the diagnosis
of primary intraocular lymphoma in patients with Masquerade
syndrome[ J]. Graefes Arch Clin Exp Ophthalmol, 2003, 241(10):
860-870.Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of
vitrectomy specimens and chorioretinal biopsies in the diagnosis
of primary intraocular lymphoma in patients with Masquerade
syndrome[ J]. Graefes Arch Clin Exp Ophthalmol, 2003, 241(10):
860-870.
44、Karma A, von Willebrand EO, Tommila PV, et al. Primary intraocular
lymphoma: improving the diagnostic procedure[ J]. Ophthalmology,
2007, 114(7): 1372-1377.Karma A, von Willebrand EO, Tommila PV, et al. Primary intraocular
lymphoma: improving the diagnostic procedure[ J]. Ophthalmology,
2007, 114(7): 1372-1377.
45、Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing
primary intraocular lymphoma[ J]. Int Ophthalmol, 2007, 27(4):
241-250.Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing
primary intraocular lymphoma[ J]. Int Ophthalmol, 2007, 27(4):
241-250.
46、Margolis R. Diagnostic vitrectomy for the diagnosis and management
of posterior uveitis of unknown etiology[ J]. Curr Opin Ophthalmol,
2008, 19(3): 218-224.Margolis R. Diagnostic vitrectomy for the diagnosis and management
of posterior uveitis of unknown etiology[ J]. Curr Opin Ophthalmol,
2008, 19(3): 218-224.
47、Davis JL. Intraocular lymphoma: a clinical perspective[ J]. Eye (Lond),
2013, 27(2): 153-162.Davis JL. Intraocular lymphoma: a clinical perspective[ J]. Eye (Lond),
2013, 27(2): 153-162.
48、Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in
primary vitreoretinal lymphoma[ J]. Retina, 2011, 31(3): 435-440.Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in
primary vitreoretinal lymphoma[ J]. Retina, 2011, 31(3): 435-440.
49、Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular
lymphoma by polymerase chain reaction analysis and cytokine profiling
of the vitreous fluid[ J]. Jpn J Ophthalmol, 2009, 53(3): 209-214.Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular
lymphoma by polymerase chain reaction analysis and cytokine profiling
of the vitreous fluid[ J]. Jpn J Ophthalmol, 2009, 53(3): 209-214.
50、Narasimhan S, Joshi M, Parameswaran S, et al. MYD88 L265P mutation
in intraocular lymphoma: A potential diagnostic marker[ J]. Indian J
Ophthalmol, 2020, 68(10): 2160-2165.Narasimhan S, Joshi M, Parameswaran S, et al. MYD88 L265P mutation
in intraocular lymphoma: A potential diagnostic marker[ J]. Indian J
Ophthalmol, 2020, 68(10): 2160-2165.
51、Pulido JS, Salomao DR, Frederick LA, et al. MyD-88 L265P mutations
are present in some cases of vitreoretinal lymphoma[ J]. Retina, 2015,
35(4): 624-627.Pulido JS, Salomao DR, Frederick LA, et al. MyD-88 L265P mutations
are present in some cases of vitreoretinal lymphoma[ J]. Retina, 2015,
35(4): 624-627.
52、Raja H, Salom?o DR, Viswanatha DS, et al. Prevalence of myd88 l265p
mutation in histologically proven, diffuse large B-cell vitreoretinal
lymphoma[ J]. Retina, 2016, 36(3): 624-628.Raja H, Salom?o DR, Viswanatha DS, et al. Prevalence of myd88 l265p
mutation in histologically proven, diffuse large B-cell vitreoretinal
lymphoma[ J]. Retina, 2016, 36(3): 624-628.
53、Wallace DJ, Shen D, Reed GF, et al. Detection of the bcl-2 t(14;18)
translocation and proto-oncogene expression in primary intraocular
lymphoma[ J]. Invest Ophthalmol Vis Sci, 2006, 47(7): 2750-2756.Wallace DJ, Shen D, Reed GF, et al. Detection of the bcl-2 t(14;18)
translocation and proto-oncogene expression in primary intraocular
lymphoma[ J]. Invest Ophthalmol Vis Sci, 2006, 47(7): 2750-2756.
54、Tagawa Y, Namba K, Ogasawara R, et al. A case of mature natural
killer-cell neoplasm manifesting multiple choroidal lesions: primary
intraocular natural killer-cell lymphoma[ J]. Case Rep Ophthalmol,
2015, 6(3): 380-384.Tagawa Y, Namba K, Ogasawara R, et al. A case of mature natural
killer-cell neoplasm manifesting multiple choroidal lesions: primary
intraocular natural killer-cell lymphoma[ J]. Case Rep Ophthalmol,
2015, 6(3): 380-384.
55、Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular
lymphoma[ J]. Surv Ophthalmol, 2014, 59(5): 503-516.Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular
lymphoma[ J]. Surv Ophthalmol, 2014, 59(5): 503-516.
56、Stübiger N, Kakkassery V, Gundlach E, et al. Diagnostics and treatment
of primary vitreoretinal lymphoma[ J]. Ophthalmologe, 2015, 112(3):
223-230.Stübiger N, Kakkassery V, Gundlach E, et al. Diagnostics and treatment
of primary vitreoretinal lymphoma[ J]. Ophthalmologe, 2015, 112(3):
223-230.
57、Itty S, Olson JH, O'Connell DJ, et al. Treatment of primary intraocular
lymphoma (PIOL) has involved systemic, intravitreal or intrathecal
chemotherapy and/or radiotherapy[ J]. Retina, 2009, 29(3): 415-416.Itty S, Olson JH, O'Connell DJ, et al. Treatment of primary intraocular
lymphoma (PIOL) has involved systemic, intravitreal or intrathecal
chemotherapy and/or radiotherapy[ J]. Retina, 2009, 29(3): 415-416.
58、Kim H, Csaky KG, Chan CC, et al. The pharmacokinetics of
rituximab following an intravitreal injection[ J]. Exp Eye Res, 2006,
82(5): 760-766.Kim H, Csaky KG, Chan CC, et al. The pharmacokinetics of
rituximab following an intravitreal injection[ J]. Exp Eye Res, 2006,
82(5): 760-766.
59、Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of
rituximab[ J]. Eye (Lond), 2007, 21(12): 1524-1527.Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of
rituximab[ J]. Eye (Lond), 2007, 21(12): 1524-1527.
60、Fishburne BC, Wilson DJ, Rosenbaum JT, et al. Intrav itreal
methotrexate as an adjunctive treatment of intraocular lymphoma[ J].
Arch Ophthalmol, 1997, 115(9): 1152-1156.Fishburne BC, Wilson DJ, Rosenbaum JT, et al. Intrav itreal
methotrexate as an adjunctive treatment of intraocular lymphoma[ J].
Arch Ophthalmol, 1997, 115(9): 1152-1156.
61、de Smet MD, Vancs VS, Kohler D, et al. Intravitreal chemotherapy for
the treatment of recurrent intraocular lymphoma[ J]. Br J Ophthalmol,
1999, 83(4): 448-451.de Smet MD, Vancs VS, Kohler D, et al. Intravitreal chemotherapy for
the treatment of recurrent intraocular lymphoma[ J]. Br J Ophthalmol,
1999, 83(4): 448-451.
62、de Smet MD. Management of non Hodgkin's intraocular lymphoma
with intravitreal methotrexate[ J]. Bull Soc Belge Ophtalmol,
2001(279): 91-95.de Smet MD. Management of non Hodgkin's intraocular lymphoma
with intravitreal methotrexate[ J]. Bull Soc Belge Ophtalmol,
2001(279): 91-95.
63、Tempescul A, Pradier O, Marianowski-Cochard C, et al. Combined
therapy associating systemic platinum-based chemotherapy and local
radiotherapy into the treatment of primary intraocular lymphoma[ J].
Ann Hematol, 2011, 90(9): 1117-1118.Tempescul A, Pradier O, Marianowski-Cochard C, et al. Combined
therapy associating systemic platinum-based chemotherapy and local
radiotherapy into the treatment of primary intraocular lymphoma[ J].
Ann Hematol, 2011, 90(9): 1117-1118.
64、Korfel A, Schlegel U. Diagnosis and treatment of primary CNS
lymphoma[ J]. Nat Rev Neurol, 2013, 9(6): 317-327.Korfel A, Schlegel U. Diagnosis and treatment of primary CNS
lymphoma[ J]. Nat Rev Neurol, 2013, 9(6): 317-327.
65、Sen HN, Chan CC, Byrnes G, et al. Intravitreal methotrexate resistance
in a patient with primary intraocular lymphoma[ J]. Ocul Immunol
Inflamm, 2008, 16(1): 29-33.Sen HN, Chan CC, Byrnes G, et al. Intravitreal methotrexate resistance
in a patient with primary intraocular lymphoma[ J]. Ocul Immunol
Inflamm, 2008, 16(1): 29-33.
66、Mason JO, Fischer DH, et al. Intrathecal chemotherapy for recurrent
central nervous system intraocular lymphoma[ J]. Ophthalmology,
2003, 110(6): 1241-1244.Mason JO, Fischer DH, et al. Intrathecal chemotherapy for recurrent
central nervous system intraocular lymphoma[ J]. Ophthalmology,
2003, 110(6): 1241-1244.
67、Ghesquieres H, Chevrier M, Laadhari M, et al. Lenalidomide in
combination with intravenous rituximab (REVRI) in relapsed/
refractory primary CNS lymphoma or primary intraocular lymphoma:
a multicenter prospective 'proof of concept' phase II study of the French
Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study
Association (LYSA)?[ J]. Ann Oncol, 2019, 30(4): 621-628.Ghesquieres H, Chevrier M, Laadhari M, et al. Lenalidomide in
combination with intravenous rituximab (REVRI) in relapsed/
refractory primary CNS lymphoma or primary intraocular lymphoma:
a multicenter prospective 'proof of concept' phase II study of the French
Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study
Association (LYSA)?[ J]. Ann Oncol, 2019, 30(4): 621-628.
68、Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous
system lymphoma: clinical features, diagnosis, and outcomes[ J].
Ophthalmology, 1999, 106(9): 1805-1810.Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous
system lymphoma: clinical features, diagnosis, and outcomes[ J].
Ophthalmology, 1999, 106(9): 1805-1810.
69、Dunleavy K, Wilson WH, et al. Primary intraocular lymphoma: current
and future perspectives[ J]. Leuk Lymphoma, 2006, 47(9): 1726-1727.Dunleavy K, Wilson WH, et al. Primary intraocular lymphoma: current
and future perspectives[ J]. Leuk Lymphoma, 2006, 47(9): 1726-1727.
70、Isobe K, Ejima Y, Tokumaru S, et al. Treatment of primary intraocular
lymphoma with radiation therapy: a multi-institutional survey in
Japan[ J]. Leuk Lymphoma, 2006, 47(9): 1800-1805.Isobe K, Ejima Y, Tokumaru S, et al. Treatment of primary intraocular
lymphoma with radiation therapy: a multi-institutional survey in
Japan[ J]. Leuk Lymphoma, 2006, 47(9): 1800-1805.
71、Kim MM, Dabaja BS, Medeiros J, et al. Survival outcomes of primary
intraocular lymphoma: a single-institution experience[ J]. Am J Clin
Oncol, 2016, 39(2): 109-113.Kim MM, Dabaja BS, Medeiros J, et al. Survival outcomes of primary
intraocular lymphoma: a single-institution experience[ J]. Am J Clin
Oncol, 2016, 39(2): 109-113.
72、Lee S, Kim MJ, Kim JS, et al. Intraocular lymphoma in Korea: the
Consortium for Improving Survival of Lymphoma (CISL) study[ J].
Blood Res, 2015, 50(4): 242-247.Lee S, Kim MJ, Kim JS, et al. Intraocular lymphoma in Korea: the
Consortium for Improving Survival of Lymphoma (CISL) study[ J].
Blood Res, 2015, 50(4): 242-247.
73、Jahnke K, Thiel E, Bechrakis NE, et al. Ifosfamide or trofosfamide in
patients with intraocular lymphoma[ J]. J Neurooncol, 2009, 93(2):
213-217.Jahnke K, Thiel E, Bechrakis NE, et al. Ifosfamide or trofosfamide in
patients with intraocular lymphoma[ J]. J Neurooncol, 2009, 93(2):
213-217.
74、Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for
treating vitreoretinal lymphoma: 10 years of experience[ J]. Br J
Ophthalmol, 2008, 92(3): 383-388.Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for
treating vitreoretinal lymphoma: 10 years of experience[ J]. Br J
Ophthalmol, 2008, 92(3): 383-388.
75、Mohammad M, Andrews RM, Plowman PN, et al. Outcomes of
intravitreal methotrexate to salvage eyes with relapsed primary
intraocular lymphoma[ J]. Br J Ophthalmol, 2020 Epub ahead of print.Mohammad M, Andrews RM, Plowman PN, et al. Outcomes of
intravitreal methotrexate to salvage eyes with relapsed primary
intraocular lymphoma[ J]. Br J Ophthalmol, 2020 Epub ahead of print.
76、Wang Y, Cheung DS, Chan CC. 原发性玻璃体视网膜淋巴瘤：
个案报告及1942至2016年文献回顾[ J]. 眼科学报, 2017, 32(4):
240-251.
WANG YJ, CHEUNG DIK S, CHAN Chi-Chao. Primar y
vitreoretinal lymphoma (PVRL): report of a case and update of literature
from 1942 to 2016[ J]. Yan Ke Xue Bao, 2017, 32(4): 240-251Wang Y, Cheung DS, Chan CC. 原发性玻璃体视网膜淋巴瘤：
个案报告及1942至2016年文献回顾[ J]. 眼科学报, 2017, 32(4):
240-251.
WANG YJ, CHEUNG DIK S, CHAN Chi-Chao. Primar y
vitreoretinal lymphoma (PVRL): report of a case and update of literature
from 1942 to 2016[ J]. Yan Ke Xue Bao, 2017, 32(4): 240-251
